CLINICAL_TRIALS
trial_result
· 2014-06-18
Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer [Phase 1]
Summary
Phase 1 study evaluating ramucirumab (IMC-1121B) in participants with breast cancer has completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2014-06-18